{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Parsippany",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "ANDA077686"
        ],
        "brand_name": [
          "MATZIM LA"
        ],
        "generic_name": [
          "DILTIAZEM HYDROCHLORIDE"
        ],
        "manufacturer_name": [
          "Actavis Pharma, Inc."
        ],
        "product_ndc": [
          "52544-691",
          "52544-692",
          "52544-693",
          "52544-694",
          "52544-695"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "DILTIAZEM HYDROCHLORIDE"
        ],
        "rxcui": [
          "830877",
          "830879",
          "830882",
          "830897",
          "830900",
          "1091623",
          "1091629",
          "1091632",
          "1091635",
          "1091638"
        ],
        "spl_id": [
          "6b586f35-6eb1-488c-839e-581f695d3f07"
        ],
        "spl_set_id": [
          "e8c8dd18-9d95-4068-9762-bec1eb1bc25c"
        ],
        "package_ndc": [
          "52544-691-30",
          "52544-691-19",
          "52544-691-10",
          "52544-692-30",
          "52544-692-19",
          "52544-692-10",
          "52544-693-30",
          "52544-693-19",
          "52544-693-10",
          "52544-694-30",
          "52544-694-19",
          "52544-694-10",
          "52544-695-30",
          "52544-695-19",
          "52544-695-10"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "OLH94387TE"
        ]
      },
      "product_type": "Drugs",
      "event_id": "90635",
      "recalling_firm": "Teva Pharmaceuticals USA Inc",
      "address_1": "400 Interpace Pkwy Bldg A",
      "address_2": "N/A",
      "postal_code": "07054-1120",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "N/A",
      "distribution_pattern": "Nationwide in the USA and Puerto Rico",
      "recall_number": "D-1302-2022",
      "product_description": "Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 180 mg, 30-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, USA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, USA; NDC 52544-691-30.",
      "product_quantity": "8022 bottles",
      "reason_for_recall": "Failed Dissolution Specifications: below specification limits for dissolution.",
      "recall_initiation_date": "20220721",
      "center_classification_date": "20220804",
      "termination_date": "20230418",
      "report_date": "20220810",
      "code_info": "Lot 1411593A, Exp 09/22"
    }
  ]
}